gip/glp-1 tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy Tirzepatide, a dual GIP/GLP-1 receptor

Patients on Semaglutide have reported significant weight loss and improvements in glycemic control, which, in many cases, have led to a positive impact on their overall well-being and quality of life

Weight gain has not been reported as a side effect

Your GI system has adjusted to the slowed gastric emptying that tirzepatide causes

-25% EVERBUILD Plant Protein 17.64 / 34.50

Regular blood sugar monitoring, such as through regular A1C tests or checking fingerstick glucose levels at home, can alert the patient if their sugar levels have not sufficiently decreased

Venmo and PayPal logos are a trademark of PayPal, Inc